News / Health

Researchers Develop Vaccine to Treat Cervical Cancer

Jessica Berman
Researchers have developed an experimental vaccine to treat cervical cancer, the leading cause of cancer death among women worldwide.  

The World Health Organization estimates that about 500,000 new cases of cervical cancer are diagnosed each year, mostly among women in the poorest regions of the world - sub-Saharan Africa, Latin America and parts of Asia.  The disease kills about 274,000 women every year.
 
Most cervical cancers are caused by infection with the human papilloma virus, or HPV.  Two varieties of the sexually-transmitted disease, known as HPV types 16 and 18, cause up to 75 percent of all cervical cancers.

A vaccine already exists to prevent the acquisition and spread of HPV 16 and 18, as well as other strains of HPV that cause genital warts. The new, experimental drug is designed to treat women who already are infected with HPV and who are at risk of developing cervical cancer.

Niranjan Sardesai is chief of research and development for Inovio Pharmaceuticals, a Pennsylvania company developing the therapeutic vaccine.
 
“Globally, you know, there is a large unmet need in terms of large numbers of women and men who go unvaccinated.  So the disease burden is there.  And our vaccine, if successful, has the potential to address large populations that are HPV-infected," said Sardesai.

Unlike other vaccines that stimulate an immune response by exposing the body to a bacterial or viral protein, the cervical cancer treatment is what is called a DNA vaccine.  

Researchers make the vaccine using small bits of viral DNA that code for a specific protein.  Once injected, these DNA fragments direct the patient’s cells to produce copies of the infectious protein, or antigen, that stimulate a strong immune response against HPV-infected cells.

Again, chemist Niranjan Sardesai:

“So our approach works exactly like vaccines do, which is you immunize people with the target protein or the target antigen, have your body produce immune responses against the target antigen, with one major difference - we are asking the body to produce the target antigen on its own to which it can then produce an immune response," said Sardesai.

In a safety and effectiveness trial, the treatment stimulated a strong T-cell immune response in a small number of HPV-infected women.  The next step, according to Sardesai, is to conduct a study to see whether the vaccine eliminates HPV infection in a larger group of patients.

Sardesai says the vaccine could potentially treat several cancers stemming from human papilloma virus, including head and neck cancer, vulvar cancer in women, penile and anal cancers, and cancer of the urogenital tract.

An article describing development of the HPV treatment vaccine is published in the journal Science Translational Medicine.   

You May Like

Nigeria Incumbent in Tight Spot as Poll Nears

Muhammadu Buhari is running a strong challenge to Goodluck Jonathan, amid a faltering economy and Boko Haram security worries More

Video Liberia's Almost Last Ebola Patient Grateful but Still Grieving

Beatrice Yardolo tells VOA that despite her fame, life is still a struggle as she waits for government's promise of support to arrive More

Video Cambodian Land Grabs Threaten Traditional Communities

At least seven different indigenous groups in Ratanakiri depend mainly on forest products for their survival, say they face loss of their land, traditional way of life More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Liberia's Almost Last Ebola Patient Grateful but Still Grievingi
X
Benno Muchler
March 26, 2015 3:41 PM
Beatrice Yardolo was to make history as Liberia’s last Ebola patient. Liberians recently started counting down 42 days, the period that has to go by without a single new infection until the World Health Organization can declare a country Ebola-free. That countdown stopped on March 20 when there was another new case of Ebola, making Yardolo’s story a reminder that Ebola is far from over. Benno Muchler reports from Monrovia.
Video

Video Liberia's Almost Last Ebola Patient Grateful but Still Grieving

Beatrice Yardolo was to make history as Liberia’s last Ebola patient. Liberians recently started counting down 42 days, the period that has to go by without a single new infection until the World Health Organization can declare a country Ebola-free. That countdown stopped on March 20 when there was another new case of Ebola, making Yardolo’s story a reminder that Ebola is far from over. Benno Muchler reports from Monrovia.
Video

Video Cambodian Land Grabs Threaten Traditional Communities

Indigenous communities in Cambodia's Ratanakiri province say the government’s economic land concession policy is taking away their land and traditional way of life, making many fear that their identity will soon be lost. Local authorities, though, have denied this is the case. VOA's Say Mony went to investigate and filed this report, narrated by Colin Lovett.
Video

Video US, South Korea Conduct Joint Military Exercises

The Eighth U.S. Army Division and the Eighth Republic of Korea Mechanized Infantry Division put on a well orchestrated show of force for the media this week during their joint military training exercises in South Korea. VOA’s Seoul correspondent Brian Padden was there and reports the soldiers were well disciplined both in conducting a complex live fire exercise and in staying on message with the press.
Video

Video Space Program Status Disappoints 'Last Man on the Moon'

One of the films that drew big crowds last week at the annual South by Southwest festival in Austin, Texas, tells the story of the last human being to stand on the moon, U.S. astronaut Eugene Cernan. It has been 42 years since Cernan returned from the moon and he laments that no one else has gone there since. VOA’s Greg Flakus reports.
Video

Video Young Filmmakers Shine Spotlight on Giving Back

A group of student filmmakers from across the United States joined President Barack Obama at the White House this month for the second annual White House Student Film Festival. Fifteen short films were officially selected from more than 1,500 entries by students aged 6 through 18. The filmmakers and their families then joined the president and a group of celebrities for a screening of their films. VOA’s Julie Taboh reports.
Video

Video VOA Exclusive: Interview with Afghan President Ashraf Ghani

Afghan President Ashraf Ghani, during his first visit as president to Washington, gave a one-on-one interview with VOA Afghan Service reporter Said Suleiman Ashna, about his request for a change in U.S. troop levels, the threat from the Islamic State, and repairing relations with the United States and Pakistan. The interview was held at Blair House, late Sunday, in Pashto.
Video

Video California Science Center Tells Story of Dead Sea Scrolls

The ancient manuscripts were uncovered in the mid-20th century, and they are still yielding clues about life and religious beliefs in ancient Israel. As VOA's Mike O'Sullivan reports, an exhibit in Los Angeles shows how modern science is bringing the history of these ancient documents to life.
Video

Video Angelina Jolie Takes Another Bold Step

Hollywood actress and filmmaker Angelina Jolie has revealed she had her ovaries and fallopian tubes removed to lower her odds of getting cancer. Doctors say the huge publicity over her decision will help raise awareness about the importance of cancer screening. VOA’s George Putic has more

All About America

Circumventing Censorship

An Internet Primer for Healthy Web Habits

As surveillance and censoring technologies advance, so, too, do new tools for your computer or mobile device that help protect your privacy and break through Internet censorship.
More